SOPHiA GENETICS SA Net Change in Short-term Investments 2020-2025 | SOPH

SOPHiA GENETICS SA net change in short-term investments from 2020 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
SOPHiA GENETICS SA Annual Net Change in Short-term Investments
(Millions of US $)
2024 $N/A
2023 $18
2022 $79
2021 $22
2020 $N/A
2019 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.191B $0.065B
SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.151B 48.75
Hims & Hers Health (HIMS) United States $11.939B 124.05
Tempus AI (TEM) United States $9.210B 0.00
IRhythm Technologies (IRTC) United States $4.513B 0.00
Inspire Medical Systems (INSP) United States $4.137B 64.64
Privia Health (PRVA) United States $2.813B 192.25
Enovis (ENOV) United States $1.861B 10.37
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.579B 0.00
Phreesia (PHR) United States $1.385B 0.00
Omnicell (OMCL) United States $1.376B 24.27
Azenta (AZTA) United States $1.241B 57.66
10x Genomics (TXG) United States $1.091B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.626B 0.00
Talkspace (TALK) United States $0.495B 148.00
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.438B 0.00
Standard BioTools (LAB) United States $0.414B 0.00
TruBridge (TBRG) United States $0.358B 793.33
Outset Medical (OM) United States $0.346B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.132B 0.00
Pulmonx (LUNG) United States $0.119B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00